Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Amgen Inc. AMGN

Healthcare  —  Drug Manufacturers General
414.61 8.57 2.11% as of 25 Sep
Market cap
$219.1B
P/E
25.6×
S&P 500 Member Dividend Champion (10y) Revenue Champion (5y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Amgen Inc. (AMGN) P/E ratio

As of 25 September 2026, Amgen Inc. (AMGN) trades at a P/E ratio of 25.6×. Over the past ten years it has ranged from 13.2× (May 2019) to 75.3× (January 2018); the current reading is higher than 80% of that period. That is in line with the Drug Manufacturers General industry median of 24.7× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 22.8× (33.22%)
FY2024 34.2× 44.46%
FY2023 23.7× 10.22%
FY2022 21.5× (1.07%)
FY2021 21.7× 17.02%
FY2020 18.6× (0.31%)
FY2019 18.6× 21.35%
FY2018 15.3× (77.21%)
FY2017 67.3× 360.78%
FY2016 14.6× (17.58%)

Quarterly

Period P/E ratio Change
Jun 2026 22.3× (8.12%)
Mar 2026 24.3× 6.38%
Dec 2025 22.8× 5.46%
Sep 2025 21.7× (4.44%)
42 more quarters

Against its own ten years

Low 13.2× High 75.3×
Ten-year median 20.6×
Current reading's percentile 80

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVO Novo Nordisk A/S compare 9.5×
BMY Bristol Myers Squibb Company compare 13.8×
NVS Novartis AG compare 21.8×
AZN AstraZeneca PLC compare 24.7×
AMGN Amgen Inc. 25.6×
PFE Pfizer Inc. compare 37.7×
ABBV AbbVie Inc. compare 74.7×
MRK Merck & Co., Inc. compare 119×
Drug Manufacturers General industry median 24.7×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on AMGN